Delays, Closures and Cancellations Due to Winter Weather

Here are the Christiana Care Health System delays, closures and cancellations due to the winter storm on Wednesday, February 20, 2019. Check back for updates.

Closures & Cancellations:

  • The Brain Aneurysm Support Group meeting scheduled on Wednesday, February 20 from 5:30 to 6:30 p.m. is canceled.
  • The Breastfeeding Support Group scheduled for Wednesday, February 20 is canceled.

Christiana Care Health System’s essential hospital and emergency services, including the Emergency Departments at Christiana and Wilmington hospitals and Middletown, are open and will continue to operate without interruption. If you have any questions about the cancellation of your appointment, please call your physician.

Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, Christiana Care is implementing a temporary visitation age restriction starting Friday, Jan. 18. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services. We began restricting visitors under the age of 16 years in our Neonatal Intensive Care Unit (NICU) and Women’s and Children’s areas on Jan. 18.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.

Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, Christiana Care está implementando una restricción temporal en la edad de visitantes a partir del viernes 18 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios. Comenzamos la restricción de visitas a menores de 16 años en nuestra Unidad de Cuidados Intensivos Neonatales (NICU) y en las áreas para Mujeres y Niños desde el 18 de enero.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Physicians & Staff

Bruce M. Boman, M.D., Ph.D., MSPH, FACP

Medical Director, Cancer Genetics and Stem Cell Biology

Renowned for his work in colorectal cancer, and a cancer survivor himself since 2000, Bruce M. Boman, M.D., Ph.D., is an attending physician and director for Cancer Genetics and Stem Cell Biology for Christiana Care’s Helen F. Graham Cancer Center & Research Institute. He also represents the Graham Cancer Center as a scientist with the Center for Translational Cancer Research.

Dr. Boman’s long term career goal is to identify cancer stem cell based mechanisms that will lead to the development of new more effective, potentially even curative or preventive, treatments for cancer. Based on the emerging paradigm in oncology, effective agents will need to target cancer stem cells, which are the cells that become overpopulated during tumorigenesis and drive tumor growth. Dr. Bomann demonstrated that APC, via TCF4, regulates survivin expression and that APC, when mutant, leads to survivin overexpression and contributes to the stem cell overpopulation during colon tumorigenesis. Dr. Boman’s work also showed that survivin expression is upregulated in ApcMin/+ mice in association with Tcf4 activation and intestinal tumorigenesis. In addition, Dr. Boman’s work reported that stem cell overproduction results from increased symmetric stem cell division. Our recent research findings led to the discovery that ALDH1 is a marker for colonic stem cells and allows tracking of stem cell overpopulation during colon cancer development and isolation of cancer stem cells.

Dr. Boman’s overall hypothesis is “APC mutations that drive growth of colon cancers do so by causing stem cell overpopulation.” Dr. Boman recently published a novel model that provides a mechanism that explains how APC regulates crypt fission and, when mutant, how APC leads to abnormal crypt fission, colonic stem cell overpopulation and adenoma development.

Dr. Boman has been involved in research on APC and GI tumorigenesis for over 20 years and have vast expertise in quantitative immunohistochemical mapping of cell populations in mouse and human intestinal crypts as well as efficacy studies of chemopreventive agents using Apc Min mice. While Dr. Boman has significant experience as a laboratory chief investigating the molecular and cellular etiology of colon cancer, he is also a clinical investigator and has been integrally involved in translational efforts at all levels to advance the discoveries of cancer research to the benefit of oncology patients.

Dr. Boman served as the national princiapl investigator of the NSABP colon cancer statin prevention trial to investigate the efficacy of rosuvastatin in preventing adenomas. In addition, he has made numerous contributions to the field through publications, presentations, as a patient advocate, and service as a member on many NIH committees and study sections.

Specialties: Internal Medicine
Medical Oncology

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2229
Newark, DE 19718

Education: University of Minnesota Medical School
Residency: Mayo Clinic
Fellowship: Mayo Clinic